Oncotelic Therapeutics Files 2024 10-K
Ticker: OTLC · Form: 10-K · Filed: Apr 15, 2025 · CIK: 908259
| Field | Detail |
|---|---|
| Company | Oncotelic Therapeutics, Inc. (OTLC) |
| Form Type | 10-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Oncotelic Therapeutics filed its 2024 10-K, detailing financials and operations for the year ending Dec 31, 2024.
AI Summary
Oncotelic Therapeutics, Inc. filed its 2024 10-K on April 15, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Mateon Therapeutics Inc. and Oxigene Inc., is focused on pharmaceutical preparations. The filing details its financial position and business operations for the period.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Oncotelic Therapeutics' financial health and operational performance for the fiscal year 2024, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Oncotelic Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-04-15 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Oncotelic Therapeutics, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-04-15 (date) — Filing date
- Mateon Therapeutics Inc. (company) — Former company name
- Oxigene Inc. (company) — Former company name
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary business of Oncotelic Therapeutics, Inc.?
Oncotelic Therapeutics, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code [2834].
When did Oncotelic Therapeutics, Inc. file its 10-K report?
The 10-K report was filed on April 15, 2025.
What fiscal year does this 10-K report cover?
This 10-K report covers the fiscal year ending December 31, 2024.
What were some of the former names of Oncotelic Therapeutics, Inc.?
Oncotelic Therapeutics, Inc. was formerly known as Mateon Therapeutics Inc. and Oxigene Inc.
Where is Oncotelic Therapeutics, Inc. located?
The company's business and mailing address is 29397 AGOURA RD. #107, AGUORA HILLS, CA 91301.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 15, 2025 regarding Oncotelic Therapeutics, Inc. (OTLC).